NMR:NYSENomura Holdings Inc Analysis

Nomura Holdings trades at $8.61, sitting just above its 20‑day SMA (≈8.13) but below the 50‑day SMA (≈8.39), indicating a price that is still testing short‑term support while the longer trend remains neutral. The RSI of roughly 60 points to modest upward momentum without being overbought, and a bullish MACD histogram reinforces the potential for a continued climb toward the identified resistance around $8.75. Fundamentally, the stock appears undervalued with a trailing P/E near 11 versus an industry average of 17.7, a price‑to‑book close to 1.1, and a dividend yield of nearly 4.8% supported by a payout ratio just above 50%.
Recent material news adds a mixed flavor: growing short interest raises caution, yet JPMorgan’s upgrade to Overweight and a notable investment by billionaire Ken Fisher signal confidence in upside, echoed by a consensus price target of $9.37 (≈8% upside). The company’s solid revenue growth (~10%), strong gross margin (≈79%), and attractive dividend are tempered by a very high debt‑to‑equity ratio and elevated 30‑day volatility (≈34%), suggesting that while the valuation is appealing, risk management remains essential.